Literature DB >> 26612643

Overview of PAF-Degrading Enzymes.

Ken Karasawa1, Keizo Inoue2.   

Abstract

Because the acetyl group of 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) is essential for its biological activity, the degradation of PAF is the most important mechanism that regulates the level of PAF. The enzyme that catalyzes the hydrolysis of acetyl group at the sn-2 position of PAF was termed PAF-acetylhydrolase (PAF-AH). Subsequent research revealed that the PAF-AH family includes intracellular forms called PAF-AH I and PAF-AH II as well as an extracellular isoform, plasma PAF-AH. PAF-AH I forms a complex consisting of catalytic subunits α1, α2, and β regulatory subunits. PAF-AH I was identified from the brain, and previous studies focused on the role of PAF-AH I in brain development. However, subsequent studies found that PAF-AH I is involved in diverse functions such as spermatogenesis, amyloid-β generation, cancer pathogenesis, and protein trafficking. Another intracellular enzyme, PAF-AH II, has no homology with PAF-AH I, although this enzyme shares sequence similarity to plasma PAF-AH. Because PAF-AH preferentially hydrolyzes oxidatively modulated or truncated phospholipids, it is considered to play a protective role against oxidative stress. Homologs of this enzyme are widely distributed among evolutionarily diverse organisms. For example, studies of Caenorhabditis elegans PAF-AH II demonstrate its contribution to epidermal morphogenesis. Extracellular plasma PAF-AH associates strongly with plasma lipoproteins. Because PAF-AH is mainly associated with LDL particles, it is considered to play an anti-inflammatory role by removing oxidized phospholipids generated in LDLs exposed to oxidative stress. In this overview, we describe the crucial roles of these three PAF-degrading enzymes in cell function and cell pathology.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lp-PLA(2); PAF-AH I; PAF-AH II; Plasma PAF-AH; Platelet-activating factor acetylhydrolase

Year:  2015        PMID: 26612643     DOI: 10.1016/bs.enz.2015.09.006

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  8 in total

Review 1.  The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

2.  A pro-metastatic tRNA fragment drives Nucleolin oligomerization and stabilization of its bound metabolic mRNAs.

Authors:  Xuhang Liu; Wenbin Mei; Veena Padmanaban; Hanan Alwaseem; Henrik Molina; Maria C Passarelli; Bernardo Tavora; Sohail F Tavazoie
Journal:  Mol Cell       Date:  2022-06-01       Impact factor: 19.328

Review 3.  UVB-Induced Microvesicle Particle Release and Its Effects on the Cutaneous Microenvironment.

Authors:  Timothy C Frommeyer; Michael M Gilbert; Garrett V Brittain; Tongfan Wu; Trang Q Nguyen; Craig A Rohan; Jeffrey B Travers
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

Review 4.  Coenzyme-A-Independent Transacylation System; Possible Involvement of Phospholipase A2 in Transacylation.

Authors:  Atsushi Yamashita; Yasuhiro Hayashi; Naoki Matsumoto; Yoko Nemoto-Sasaki; Takanori Koizumi; Yusuke Inagaki; Saori Oka; Takashi Tanikawa; Takayuki Sugiura
Journal:  Biology (Basel)       Date:  2017-03-30

5.  Plasma Metabolomics Analysis Identifies Abnormal Energy, Lipid, and Amino Acid Metabolism in Abdominal Aortic Aneurysms.

Authors:  Yaming Guo; Shuwei Wan; Mingli Han; Yubo Zhao; Chuang Li; Gaopo Cai; Shuai Zhang; Zhi Sun; Xinhua Hu; Hui Cao; Zhen Li
Journal:  Med Sci Monit       Date:  2020-12-01

6.  Switching the substrate specificity of lysoplasmalogen-specific phospholipase D.

Authors:  Takayuki Oyama; Kazutaka Murayama; Daisuke Sugimori
Journal:  FEBS Open Bio       Date:  2021-03-19       Impact factor: 2.693

Review 7.  The Roles of Phospholipase A2 in Phagocytes.

Authors:  Deepti Dabral; Geert van den Bogaart
Journal:  Front Cell Dev Biol       Date:  2021-06-10

Review 8.  Inflammation, not Cholesterol, Is a Cause of Chronic Disease.

Authors:  Alexandros Tsoupras; Ronan Lordan; Ioannis Zabetakis
Journal:  Nutrients       Date:  2018-05-12       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.